Please Wait
Applying Filters...

Annual Sales of Azithromycin reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 189Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Zithromax

02 9Zithromax/Zmax

PharmaCompass

01

Brand Name : Zithromax/Zmax

Azithromycin

arrow
2024 ISPE Annual Meeting
Not Confirmed

Brand Name : Zithromax/Zmax

arrow
2024 ISPE Annual Meeting
Not Confirmed

Azithromycin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 336

2018 Revenue in Millions : 326

Growth (%) : 3

blank

02

Brand Name : Zithromax/Zmax

Azithromycin

arrow
2024 ISPE Annual Meeting
Not Confirmed

Brand Name : Zithromax/Zmax

arrow
2024 ISPE Annual Meeting
Not Confirmed

Azithromycin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 276

2019 Revenue in Millions : 336

Growth (%) : -18

blank

03

Brand Name : Zithromax/Zmax

Azithromycin

arrow
2024 ISPE Annual Meeting
Not Confirmed

Brand Name : Zithromax/Zmax

arrow
2024 ISPE Annual Meeting
Not Confirmed

Azithromycin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 278

2020 Revenue in Millions : 276

Growth (%) : 1

blank

04

Brand Name : Zithromax/Zmax

Azithromycin

arrow
2024 ISPE Annual Meeting
Not Confirmed

Brand Name : Zithromax/Zmax

arrow
2024 ISPE Annual Meeting
Not Confirmed

Azithromycin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 331

2021 Revenue in Millions : 278

Growth (%) : 19

blank

05

Brand Name : Zithromax/Zmax

Azithromycin

arrow